$279 Million is the total value of Ghost Tree Capital, LLC's 47 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $25,561,000 | +33.6% | 190,000 | +58.3% | 9.16% | +63.8% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $15,366,000 | +133.1% | 325,000 | +62.5% | 5.51% | +185.6% |
| COGT | Buy | COGENT BIOSCIENCES INC | $14,586,000 | +15.6% | 1,700,000 | +13.3% | 5.23% | +41.7% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $13,524,000 | -1.8% | 350,000 | +37.3% | 4.85% | +20.4% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $12,856,000 | +65.6% | 350,000 | +40.0% | 4.61% | +103.0% |
| MRUS | Buy | MERUS N V | $11,130,000 | +574.5% | 350,000 | +366.7% | 3.99% | +727.6% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $9,885,000 | +71.7% | 500,000 | +42.9% | 3.54% | +110.3% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $9,545,000 | – | 500,000 | +100.0% | 3.42% | – |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $9,278,000 | -11.3% | 425,000 | +21.4% | 3.32% | +8.7% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $9,005,000 | – | 100,000 | +100.0% | 3.23% | – |
| BLU | New | BELLUS HEALTH INC NEWput | $7,173,000 | – | 891,000 | +100.0% | 2.57% | – |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $6,725,000 | +55.2% | 80,000 | +23.1% | 2.41% | +90.2% |
| PCVX | Buy | VAXCYTE INC | $5,948,000 | +46.5% | 250,000 | +56.2% | 2.13% | +79.6% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $5,775,000 | +128.2% | 500,000 | +88.7% | 2.07% | +179.7% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $5,435,000 | +24.0% | 250,000 | +25.0% | 1.95% | +52.0% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,087,000 | – | 30,000 | +100.0% | 1.82% | – |
| New | AADI BIOSCIENCE INC | $4,830,000 | – | 200,000 | +100.0% | 1.73% | – | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $4,726,000 | -4.5% | 325,000 | +18.2% | 1.69% | +17.1% |
| CMPS | Buy | COMPASS PATHWAYS PLCsponsored ads | $4,641,000 | +55.4% | 210,000 | +110.0% | 1.66% | +90.5% |
| KZR | New | KEZAR LIFE SCIENCES INC | $4,180,000 | – | 250,000 | +100.0% | 1.50% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $3,623,000 | +47.5% | 450,000 | +12.5% | 1.30% | +80.8% |
| New | PYXIS ONCOLOGY INC | $3,236,000 | – | 295,000 | +100.0% | 1.16% | – | |
| NMTR | Buy | 9 METERS BIOPHARMA INC | $3,181,000 | -11.0% | 3,250,000 | +18.2% | 1.14% | +9.1% |
| DSGN | New | DESIGN THERAPEUTICS INC | $2,890,000 | – | 135,000 | +100.0% | 1.04% | – |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $2,428,000 | +5.3% | 225,000 | +12.5% | 0.87% | +29.1% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $1,756,000 | – | 60,000 | +100.0% | 0.63% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $1,450,000 | – | 55,000 | +100.0% | 0.52% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INCcall | $1,200,000 | – | 300,000 | +100.0% | 0.43% | – |
| New | PARDES BIOSCIENCES INC | $819,000 | – | 50,000 | +100.0% | 0.29% | – | |
| CABA | Buy | CABALETTA BIO INC | $512,000 | -57.9% | 135,000 | +35.0% | 0.18% | -48.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.